Condition: Atrial Fibrillation · Sponsor: Biosense Webster, Inc.
The main purpose of this clinical study is to investigate the effectiveness workflow of the clinical use of the pulsed field (PF) ablation system (VARIPULSE™ Catheter and TRUPULSE™ Generator) when used for cardiac ablation with the new VARIPULSE™ Pro software in participants with paroxysmal atrial fibrillation (PAF; irregular heartbeat where episodes start and stop on their own, usually within seven days) and persistent atrial fibrillation (PsAF; irregular, rapid heartbeat that lasts over 7 days up to 1year and doesn't stop on its own).
This description comes directly from the study's public registry record.
Nathalie Macours · +32 2 746 30 76 · nmacours1@its.jnj.com
Always discuss trial participation with your own doctor first.
| AZORG campus Aalst Moorselbaan | Aalst, Belgium | Recruiting |
| A.Z. Sint Jan | Bruges, Belgium | Recruiting |
| Aarhus University Hospital | Aarhus N, Denmark | Recruiting |
| Hospices Civils de Lyon HCL | Bron, France | Not Yet Recruiting |
| Institut Medico chirurgical Montsouris | Paris, France | Not Yet Recruiting |
| University Hospital of the Ruhr-University of Bochum | Bad Oeynhausen, Germany | Not Yet Recruiting |
| Azienda Ospedaliera Universitaria 'Policlinico Tor Vergata' | Roma, Italy | Not Yet Recruiting |
| IRCCS Policlinico San Donato | San Donato Milanese, Italy | Not Yet Recruiting |
| Vilnius University Hospital Santaros Clinics | Vilnius, Lithuania | Recruiting |
| Erasmus MC | Rotterdam, Netherlands | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07429214